Dr. Anne Ong Lim, pediatric and infectious disease expert, recalled the anxiety-inducing Friday afternoons during her fellowship days. The usual anticipation of weekend leisure was often disrupted ...

Myint Tin Tin Htar [Opens in a new window], Serogroup epidemiology of invasive meningococcal disease (IMD) is constantly evolving, varying by time and location. Surveillance reports have indicated a ...

HEALTH experts are alarmed by the invasive meningococcal disease (IMD), with Serogroup B identified as the leading cause, accounting for approximately 68 percent of cases over the years.

“There is an inconsistent approach towards meningococcal vaccine implementation,” says Masignani. A broad and consistent immunization strategy is one route to preventing IMD outbreaks and ...

invasive meningococcal disease is a rare disease in Canada. MenB vaccines are unique in terms of their potential strain coverage and adverse event profile. Meningococcal vaccine implementation can ...

to help protect against invasive meningococcal disease (IMD) caused by bacterial serogroups A, C, W and Y. This single-vial presentation is now licenced for active immunisation of children from 2 ...

In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...

and Y strains responsible for most cases of invasive meningococcal disease (IMD) encountered in the US. GSK is currently the market leader in the meningococcal vaccine market, racking up sales of ...

The majority of invasive meningococcal disease cases in high school students are preventable if national recommendations on meningococcal conjugate vaccine are fully implemented. The results of ...